Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 276 entries
Sorted by: Best Match Show Resources per page
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice.

Clinical and molecular allergy : CMA

Petrarca C, Clemente E, Amato V, Gatta A, Cortese S, Lamolinara A, Rossi C, Zanotta S, Mistrello G, Paganelli R, Di Gioacchino M.
PMID: 27499704
Clin Mol Allergy. 2016 Aug 05;14:7. doi: 10.1186/s12948-016-0044-1. eCollection 2016.

BACKGROUND: Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) is effective for treating this condition because it is able to modify its natural...

Cite
Petrarca C, Clemente E, Amato V, et al. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clin Mol Allergy. 2016;14:7doi: 10.1186/s12948-016-0044-1.
Petrarca, C., Clemente, E., Amato, V., Gatta, A., Cortese, S., Lamolinara, A., Rossi, C., Zanotta, S., Mistrello, G., Paganelli, R., & Di Gioacchino, M. (2016). Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clinical and molecular allergy : CMA, 147. https://doi.org/10.1186/s12948-016-0044-1
Petrarca, Claudia, et al. "Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice." Clinical and molecular allergy : CMA vol. 14 (2016): 7. doi: https://doi.org/10.1186/s12948-016-0044-1
Petrarca C, Clemente E, Amato V, Gatta A, Cortese S, Lamolinara A, Rossi C, Zanotta S, Mistrello G, Paganelli R, Di Gioacchino M. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clin Mol Allergy. 2016 Aug 05;14:7. doi: 10.1186/s12948-016-0044-1. eCollection 2016. PMID: 27499704; PMCID: PMC4975903.
Copy Download .nbib Format: NLM
Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia.

Clinical and molecular allergy : CMA

Recto MT, Gabriel MT, Kulthanan K, Tantilipikorn P, Aw DC, Lee TH, Chwen CC, Mutusamy S, Hao NT, Quang VT, Canonica GW.
PMID: 29118675
Clin Mol Allergy. 2017 Nov 01;15:19. doi: 10.1186/s12948-017-0074-3. eCollection 2017.

BACKGROUND: Allergic diseases are on the rise in many parts of the world, including the Asia-Pacific (APAC) region. Second-generation antihistamines are the first-line treatment option in the management of allergic rhinitis and urticaria. International guidelines describe the management of...

Cite
Recto MT, Gabriel MT, Kulthanan K, et al. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clin Mol Allergy. 2017;15:19doi: 10.1186/s12948-017-0074-3.
Recto, M. T., Gabriel, M. T., Kulthanan, K., Tantilipikorn, P., Aw, D. C., Lee, T. H., Chwen, C. C., Mutusamy, S., Hao, N. T., Quang, V. T., & Canonica, G. W. (2017). Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clinical and molecular allergy : CMA, 1519. https://doi.org/10.1186/s12948-017-0074-3
Recto, Marysia Tiongco, et al. "Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia." Clinical and molecular allergy : CMA vol. 15 (2017): 19. doi: https://doi.org/10.1186/s12948-017-0074-3
Recto MT, Gabriel MT, Kulthanan K, Tantilipikorn P, Aw DC, Lee TH, Chwen CC, Mutusamy S, Hao NT, Quang VT, Canonica GW. Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia. Clin Mol Allergy. 2017 Nov 01;15:19. doi: 10.1186/s12948-017-0074-3. eCollection 2017. PMID: 29118675; PMCID: PMC5664819.
Copy Download .nbib Format: NLM
The retinoic acid receptor-α modulators ATRA and Ro415253 reciprocally regulate human IL-5+ Th2 cell proliferation and cytokine expression.

Clinical and molecular allergy : CMA

Wansley DL, Yin Y, Prussin C.
PMID: 24314292
Clin Mol Allergy. 2013 Dec 06;11(1):4. doi: 10.1186/1476-7961-11-4.

BACKGROUND: Th2 cytokine responses are enhanced by all trans retinoic acid (ATRA), the bioavailable form of vitamin A. Retinoic acid receptor alpha (RARα) is the high affinity receptor for ATRA that mediates these pro-Th2 effects. We have previously characterized...

Cite
Wansley DL, Yin Y, Prussin C. The retinoic acid receptor-α modulators ATRA and Ro415253 reciprocally regulate human IL-5+ Th2 cell proliferation and cytokine expression. Clin Mol Allergy. 2013;11(1):4doi: 10.1186/1476-7961-11-4.
Wansley, D. L., Yin, Y., & Prussin, C. (2013). The retinoic acid receptor-α modulators ATRA and Ro415253 reciprocally regulate human IL-5+ Th2 cell proliferation and cytokine expression. Clinical and molecular allergy : CMA, 11(1), 4. https://doi.org/10.1186/1476-7961-11-4
Wansley, Daniel L, et al. "The retinoic acid receptor-α modulators ATRA and Ro415253 reciprocally regulate human IL-5+ Th2 cell proliferation and cytokine expression." Clinical and molecular allergy : CMA vol. 11,1 (2013): 4. doi: https://doi.org/10.1186/1476-7961-11-4
Wansley DL, Yin Y, Prussin C. The retinoic acid receptor-α modulators ATRA and Ro415253 reciprocally regulate human IL-5+ Th2 cell proliferation and cytokine expression. Clin Mol Allergy. 2013 Dec 06;11(1):4. doi: 10.1186/1476-7961-11-4. PMID: 24314292; PMCID: PMC3882882.
Copy Download .nbib Format: NLM
Prevalence of positive atopy patch test in an unselected pediatric population.

Clinical and molecular allergy : CMA

Fuiano N, Diddi G, Delvecchio M, C CI.
PMID: 25954139
Clin Mol Allergy. 2015 May 07;13(1):2. doi: 10.1186/s12948-015-0011-2. eCollection 2015.

BACKGROUND: In the latest decades, epidemiological studies on allergic disorders in children, including atopic dermatitis, rhinitis and asthma, demonstrated a continuous increase in prevalence. However, such studies are usually performed by questionnaires and, sometimes, by skin prick test or...

Cite
Fuiano N, Diddi G, Delvecchio M, et al. Prevalence of positive atopy patch test in an unselected pediatric population. Clin Mol Allergy. 2015;13(1):2doi: 10.1186/s12948-015-0011-2.
Fuiano, N., Diddi, G., Delvecchio, M., & C, C. I. (2015). Prevalence of positive atopy patch test in an unselected pediatric population. Clinical and molecular allergy : CMA, 13(1), 2. https://doi.org/10.1186/s12948-015-0011-2
Fuiano, Nicola, et al. "Prevalence of positive atopy patch test in an unselected pediatric population." Clinical and molecular allergy : CMA vol. 13,1 (2015): 2. doi: https://doi.org/10.1186/s12948-015-0011-2
Fuiano N, Diddi G, Delvecchio M, C CI. Prevalence of positive atopy patch test in an unselected pediatric population. Clin Mol Allergy. 2015 May 07;13(1):2. doi: 10.1186/s12948-015-0011-2. eCollection 2015. PMID: 25954139; PMCID: PMC4423149.
Copy Download .nbib Format: NLM
Identification of risk factors of severe hypersensitivity reactions in general anaesthesia.

Clinical and molecular allergy : CMA

Mirone C, Preziosi D, Mascheri A, Micarelli G, Farioli L, Balossi LG, Scibilia J, Schroeder J, Losappio LM, Aversano MG, Stafylaraki C, Nichelatti M, Pastorello EA.
PMID: 26101469
Clin Mol Allergy. 2015 Jun 22;13(1):11. doi: 10.1186/s12948-015-0017-9. eCollection 2015.

BACKGROUND: Hypersensitivity reactions to anaesthetic agents are rare but often severe, with a mortality ranging from 4 to 9% in IgE-mediated events. Identification of the risk factors may contribute to limit the incidence of these reactions. The aim of...

Cite
Mirone C, Preziosi D, Mascheri A, et al. Identification of risk factors of severe hypersensitivity reactions in general anaesthesia. Clin Mol Allergy. 2015;13(1):11doi: 10.1186/s12948-015-0017-9.
Mirone, C., Preziosi, D., Mascheri, A., Micarelli, G., Farioli, L., Balossi, L. G., Scibilia, J., Schroeder, J., Losappio, L. M., Aversano, M. G., Stafylaraki, C., Nichelatti, M., & Pastorello, E. A. (2015). Identification of risk factors of severe hypersensitivity reactions in general anaesthesia. Clinical and molecular allergy : CMA, 13(1), 11. https://doi.org/10.1186/s12948-015-0017-9
Mirone, Corrado, et al. "Identification of risk factors of severe hypersensitivity reactions in general anaesthesia." Clinical and molecular allergy : CMA vol. 13,1 (2015): 11. doi: https://doi.org/10.1186/s12948-015-0017-9
Mirone C, Preziosi D, Mascheri A, Micarelli G, Farioli L, Balossi LG, Scibilia J, Schroeder J, Losappio LM, Aversano MG, Stafylaraki C, Nichelatti M, Pastorello EA. Identification of risk factors of severe hypersensitivity reactions in general anaesthesia. Clin Mol Allergy. 2015 Jun 22;13(1):11. doi: 10.1186/s12948-015-0017-9. eCollection 2015. PMID: 26101469; PMCID: PMC4476085.
Copy Download .nbib Format: NLM
How pregnancy can affect autoimmune diseases progression?.

Clinical and molecular allergy : CMA

Piccinni MP, Lombardelli L, Logiodice F, Kullolli O, Parronchi P, Romagnani S.
PMID: 27651750
Clin Mol Allergy. 2016 Sep 15;14:11. doi: 10.1186/s12948-016-0048-x. eCollection 2016.

Autoimmune disorders are characterized by tissue damage, caused by self-reactivity of different effectors mechanisms of the immune system, namely antibodies and T cells. Their occurrence may be associated with genetic and/or environmental predisposition and to some extent, have implications...

Cite
Piccinni MP, Lombardelli L, Logiodice F, et al. How pregnancy can affect autoimmune diseases progression?. Clin Mol Allergy. 2016;14:11doi: 10.1186/s12948-016-0048-x.
Piccinni, M. P., Lombardelli, L., Logiodice, F., Kullolli, O., Parronchi, P., & Romagnani, S. (2016). How pregnancy can affect autoimmune diseases progression?. Clinical and molecular allergy : CMA, 1411. https://doi.org/10.1186/s12948-016-0048-x
Piccinni, Marie-Pierre, et al. "How pregnancy can affect autoimmune diseases progression?." Clinical and molecular allergy : CMA vol. 14 (2016): 11. doi: https://doi.org/10.1186/s12948-016-0048-x
Piccinni MP, Lombardelli L, Logiodice F, Kullolli O, Parronchi P, Romagnani S. How pregnancy can affect autoimmune diseases progression?. Clin Mol Allergy. 2016 Sep 15;14:11. doi: 10.1186/s12948-016-0048-x. eCollection 2016. PMID: 27651750; PMCID: PMC5025626.
Copy Download .nbib Format: NLM
Drug induced exfoliative dermatitis: state of the art.

Clinical and molecular allergy : CMA

Yacoub MR, Berti A, Campochiaro C, Tombetti E, Ramirez GA, Nico A, Di Leo E, Fantini P, Sabbadini MG, Nettis E, Colombo G.
PMID: 27551239
Clin Mol Allergy. 2016 Aug 22;14:9. doi: 10.1186/s12948-016-0045-0. eCollection 2016.

Drug induced exfoliative dermatitis (ED) are a group of rare and severe drug hypersensitivity reactions (DHR) involving skin and usually occurring from days to several weeks after drug exposure. Erythema multiforme (EM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis...

Cite
Yacoub MR, Berti A, Campochiaro C, et al. Drug induced exfoliative dermatitis: state of the art. Clin Mol Allergy. 2016;14:9doi: 10.1186/s12948-016-0045-0.
Yacoub, M. R., Berti, A., Campochiaro, C., Tombetti, E., Ramirez, G. A., Nico, A., Di Leo, E., Fantini, P., Sabbadini, M. G., Nettis, E., & Colombo, G. (2016). Drug induced exfoliative dermatitis: state of the art. Clinical and molecular allergy : CMA, 149. https://doi.org/10.1186/s12948-016-0045-0
Yacoub, Mona-Rita, et al. "Drug induced exfoliative dermatitis: state of the art." Clinical and molecular allergy : CMA vol. 14 (2016): 9. doi: https://doi.org/10.1186/s12948-016-0045-0
Yacoub MR, Berti A, Campochiaro C, Tombetti E, Ramirez GA, Nico A, Di Leo E, Fantini P, Sabbadini MG, Nettis E, Colombo G. Drug induced exfoliative dermatitis: state of the art. Clin Mol Allergy. 2016 Aug 22;14:9. doi: 10.1186/s12948-016-0045-0. eCollection 2016. PMID: 27551239; PMCID: PMC4993006.
Copy Download .nbib Format: NLM
Sensitization to secretoglobin and lipocalins in a group of young children with risk of developing respiratory allergy.

Clinical and molecular allergy : CMA

Nagao M, Borres MP, Sugimoto M, Petersson CJ, Nakayama S, Kuwabara Y, Masuda S, Dykiel P, Fujisawa T.
PMID: 28270741
Clin Mol Allergy. 2017 Mar 03;15:4. doi: 10.1186/s12948-017-0061-8. eCollection 2017.

BACKGROUND: Multiple sensitizations in early age have been reported to be a risk for development of asthma. This study evaluates the emergence and evolution of IgE to aeroallergens among a cohort of children with physician-diagnosed atopic dermatitis and/or showing...

Cite
Nagao M, Borres MP, Sugimoto M, et al. Sensitization to secretoglobin and lipocalins in a group of young children with risk of developing respiratory allergy. Clin Mol Allergy. 2017;15:4doi: 10.1186/s12948-017-0061-8.
Nagao, M., Borres, M. P., Sugimoto, M., Petersson, C. J., Nakayama, S., Kuwabara, Y., Masuda, S., Dykiel, P., & Fujisawa, T. (2017). Sensitization to secretoglobin and lipocalins in a group of young children with risk of developing respiratory allergy. Clinical and molecular allergy : CMA, 154. https://doi.org/10.1186/s12948-017-0061-8
Nagao, Mizuho, et al. "Sensitization to secretoglobin and lipocalins in a group of young children with risk of developing respiratory allergy." Clinical and molecular allergy : CMA vol. 15 (2017): 4. doi: https://doi.org/10.1186/s12948-017-0061-8
Nagao M, Borres MP, Sugimoto M, Petersson CJ, Nakayama S, Kuwabara Y, Masuda S, Dykiel P, Fujisawa T. Sensitization to secretoglobin and lipocalins in a group of young children with risk of developing respiratory allergy. Clin Mol Allergy. 2017 Mar 03;15:4. doi: 10.1186/s12948-017-0061-8. eCollection 2017. PMID: 28270741; PMCID: PMC5335719.
Copy Download .nbib Format: NLM
Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario.

Clinical and molecular allergy : CMA

Giudici F, Maggi L, Santi R, Cosmi L, Annunziato F, Nesi G, Barra G, Bassotti G, De Palma R, Tonelli F.
PMID: 26203298
Clin Mol Allergy. 2015 Jul 22;13(1):12. doi: 10.1186/s12948-015-0018-8. eCollection 2015.

BACKGROUND: Crohn's disease (CD) and Hidradenitis suppurativa (HS) are both chronic inflammatory diseases. The pathogenesis of these diseases is multifactorial, due to the interaction of genetic and environmental factors leading to a deregulated local immune response where T lymphocytes...

Cite
Giudici F, Maggi L, Santi R, et al. Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario. Clin Mol Allergy. 2015;13(1):12doi: 10.1186/s12948-015-0018-8.
Giudici, F., Maggi, L., Santi, R., Cosmi, L., Annunziato, F., Nesi, G., Barra, G., Bassotti, G., De Palma, R., & Tonelli, F. (2015). Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario. Clinical and molecular allergy : CMA, 13(1), 12. https://doi.org/10.1186/s12948-015-0018-8
Giudici, Francesco, et al. "Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario." Clinical and molecular allergy : CMA vol. 13,1 (2015): 12. doi: https://doi.org/10.1186/s12948-015-0018-8
Giudici F, Maggi L, Santi R, Cosmi L, Annunziato F, Nesi G, Barra G, Bassotti G, De Palma R, Tonelli F. Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario. Clin Mol Allergy. 2015 Jul 22;13(1):12. doi: 10.1186/s12948-015-0018-8. eCollection 2015. PMID: 26203298; PMCID: PMC4511252.
Copy Download .nbib Format: NLM
Hypersensitivity pneumonitis: a complex lung disease.

Clinical and molecular allergy : CMA

Riario Sforza GG, Marinou A.
PMID: 28286422
Clin Mol Allergy. 2017 Mar 07;15:6. doi: 10.1186/s12948-017-0062-7. eCollection 2017.

Hypersensitivity pneumonitis (HP), also called extrinsic allergic alveolitis, is a respiratory syndrome involving the lung parenchyma and specifically the alveoli, terminal bronchioli, and alveolar interstitium, due to a delayed allergic reaction. Such reaction is secondary to a repeated and...

Cite
Riario Sforza GG, Marinou A. Hypersensitivity pneumonitis: a complex lung disease. Clin Mol Allergy. 2017;15:6doi: 10.1186/s12948-017-0062-7.
Riario Sforza, G. G., & Marinou, A. (2017). Hypersensitivity pneumonitis: a complex lung disease. Clinical and molecular allergy : CMA, 156. https://doi.org/10.1186/s12948-017-0062-7
Riario Sforza, Gian Galeazzo, and Marinou, Androula. "Hypersensitivity pneumonitis: a complex lung disease." Clinical and molecular allergy : CMA vol. 15 (2017): 6. doi: https://doi.org/10.1186/s12948-017-0062-7
Riario Sforza GG, Marinou A. Hypersensitivity pneumonitis: a complex lung disease. Clin Mol Allergy. 2017 Mar 07;15:6. doi: 10.1186/s12948-017-0062-7. eCollection 2017. PMID: 28286422; PMCID: PMC5339989.
Copy Download .nbib Format: NLM
Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy.

Clinical and molecular allergy : CMA

Savi E, Peveri S, Incorvaia C, Dell'Albani I, Marcucci F, Di Cara G, Frati F.
PMID: 24308506
Clin Mol Allergy. 2013 Dec 05;11(1):3. doi: 10.1186/1476-7961-11-3.

BACKGROUND: The introduction of component-resolved diagnosis was a great advance in diagnosis of allergy. In particular, molecular allergy techniques allowed investigation of the association between given molecular profiles and clinical expression of allergy. We evaluated the possible correlation between...

Cite
Savi E, Peveri S, Incorvaia C, et al. Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy. Clin Mol Allergy. 2013;11(1):3doi: 10.1186/1476-7961-11-3.
Savi, E., Peveri, S., Incorvaia, C., Dell'Albani, I., Marcucci, F., Di Cara, G., & Frati, F. (2013). Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy. Clinical and molecular allergy : CMA, 11(1), 3. https://doi.org/10.1186/1476-7961-11-3
Savi, Eleonora, et al. "Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy." Clinical and molecular allergy : CMA vol. 11,1 (2013): 3. doi: https://doi.org/10.1186/1476-7961-11-3
Savi E, Peveri S, Incorvaia C, Dell'Albani I, Marcucci F, Di Cara G, Frati F. Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy. Clin Mol Allergy. 2013 Dec 05;11(1):3. doi: 10.1186/1476-7961-11-3. PMID: 24308506; PMCID: PMC4176493.
Copy Download .nbib Format: NLM
Erratum to: Guidelines for the use and interpretation of diagnostic methods in adult food allergy.

Clinical and molecular allergy : CMA

Macchia D, Melioli G, Pravettoni V, Nucera E, Piantanida M, Caminati M, Campochiaro C, Yacoub MR, Schiavino D, Paganelli R, Di Gioacchino M.
PMID: 26696778
Clin Mol Allergy. 2015 Dec 21;13:31. doi: 10.1186/s12948-015-0037-5. eCollection 2015.

[This corrects the article DOI: 10.1186/s12948-015-0033-9.].

Cite
Macchia D, Melioli G, Pravettoni V, et al. Erratum to: Guidelines for the use and interpretation of diagnostic methods in adult food allergy. Clin Mol Allergy. 2015;13:31doi: 10.1186/s12948-015-0037-5.
Macchia, D., Melioli, G., Pravettoni, V., Nucera, E., Piantanida, M., Caminati, M., Campochiaro, C., Yacoub, M. R., Schiavino, D., Paganelli, R., Di Gioacchino, M. (2015). Erratum to: Guidelines for the use and interpretation of diagnostic methods in adult food allergy. Clinical and molecular allergy : CMA, 1331. https://doi.org/10.1186/s12948-015-0037-5
Macchia, Donatella, et al. "Erratum to: Guidelines for the use and interpretation of diagnostic methods in adult food allergy." Clinical and molecular allergy : CMA vol. 13 (2015): 31. doi: https://doi.org/10.1186/s12948-015-0037-5
Macchia D, Melioli G, Pravettoni V, Nucera E, Piantanida M, Caminati M, Campochiaro C, Yacoub MR, Schiavino D, Paganelli R, Di Gioacchino M. Erratum to: Guidelines for the use and interpretation of diagnostic methods in adult food allergy. Clin Mol Allergy. 2015 Dec 21;13:31. doi: 10.1186/s12948-015-0037-5. eCollection 2015. PMID: 26696778; PMCID: PMC4687358.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 276 entries